Article
ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway.
Science signaling - 9 Feb 2010
Kuo Hsu-Ping, Lee Dung-Fang, Chen Chun-Te, Liu Mo, Chou Chao-Kai, Lee Hong-Jen, Du Yi, Xie Xiaoming, Wei Yongkun, Xia Weiya, Weihua Zhang, Yang Jer-Yen, Yen Chia-Jui, Huang Tzu-Hsuan, Tan Minjia, Xing Gang, Zhao Yingming, Lin Chien-Hsing, Tsai Shih-Feng, Fidler Isaiah J, Hung Mien-Chie
Abstract excerpt
Mammalian target of rapamycin (mTOR) regulates various cellular functions, including tumorigenesis, and is inhibited by the tuberous sclerosis 1 (TSC1)-TSC2 complex. Here, we demonstrate that arrest-defective protein 1 (ARD1) physically interacts with, acetylates, and stabilizes TSC2, thereby repressing mTOR activity. The inhibition of mTOR by ARD1 inhibits cell proliferation and increases autophagy, thereby...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
